The Board of Directors of Impact Healthcare REIT plc (the “Board“) (ticker: IHR), the real estate investment trust which gives investors exposure to a diversified portfolio of UK healthcare real estate assets, in particular care homes, is in advanced negotiations to acquire an identified portfolio of UK care homes and, in addition, the Company has a significant pipeline of attractive investment opportunities.
The Company has invested or committed the majority of the £240 million of equity and debt capital raised since its IPO in March 2017, and is proposing to undertake an equity fundraising targeting £150 million to enable it to acquire this identified portfolio. The Company will meet with shareholders over the coming weeks, with further announcements to be made in due course.
The potential portfolio acquisition and identified pipeline of assets are in line with the Company’s investment criteria and return profile and are expected to deliver further value for its shareholders.
Target Portfolio of UK Care Homes and Possible Fundraising
The Company is currently in advanced negotiations to acquire a portfolio of UK care homes with over 2,500 beds (the “Target Portfolio“). The total annual rent on the Target Portfolio is approximately £12 million under the existing leases.
The potential acquisition of the Target Portfolio, as well as the other pipeline acquisitions, are in line with the Company’s strategy of identifying portfolios that can not only provide a strong level of income to support the Company’s dividend but also have scope for asset management opportunities that are expected to create value.
The Company’s investment adviser, Impact Health Partners LLP (the “Investment Adviser“), has categorised the assets in the Target Portfolio as follows:
- care homes which are operationally strong with a good level of rental cover, have high occupancy levels and a consistent trading performance as well as the potential to increase value, including through improved lease arrangements (the “Core Portfolio“);
- care homes that would benefit from investment by the Group, redevelopment, change of use and/or disposal (the “Non-Core Portfolio“).
Based on the agreed acquisition price, the net initial yield for the whole Target Portfolio is in excess of 8%.
The Core Portfolio, which comprises over 80% of the Target Portfolio by value, has strong levels of rental cover, supported by good levels of occupancy which has ranged between 90% and 93% over the past five years. At present, over 87% of the Core Portfolio homes in England are rated Good or Outstanding by the CQC. The Investment Adviser believes the acquisition price reflects a substantial discount to replacement build cost which limits downside exposure. Asset management opportunities exist within the Core Portfolio that will provide the potential for income and valuation enhancing investment over time.
The Non-Core Portfolio, which accounts for under 20% of the Target Portfolio by value, is being acquired at a price which reflects the current level of performance of the Non-Core homes and represents a modest premium to land values. The Investment Adviser considers that the Non-Core Portfolio represents an exciting opportunity to generate value for the Company and its shareholders through:
(i) operational turnarounds;
(ii) capital expenditure to improve performance; and
(iii) redevelopment or change of use / disposal.
The Board believes that the expertise and experience of the Investment Adviser team in managing and improving portfolios of a similar type and size to the Target Portfolio will enable the Company to pursue this accretive and value-enhancing acquisition. In addition to the financial benefits of the transaction, it will also further diversify the Group by tenant base and the geographic location of its assets.
The Company intends to enter into a sale and purchase agreement, subject to financing, to acquire the Target Portfolio, and further details relating to the Target Portfolio will be announced in due course.
The Company proposes to undertake an equity fundraising targeting £150 million to finance the acquisition of the Target Portfolio and will meet with shareholders and publish a prospectus over the coming weeks. The Company intends to appoint Winterflood Securities Limited and RBC Capital Markets as joint bookrunners in connection with the potential fundraising.
Other Pipeline Acquisitions
In addition to the Target Portfolio, the Investment Adviser is continuing to make good progress with a significant pipeline of UK assets which meet the Company’s investment objectives and investment policy, including off-market assets identified through the Investment Adviser’s extensive network of industry relationships.
The Investment Adviser has entered into negotiations in relation to the acquisition of specific target assets on behalf of the Group and, as a result of these negotiations, has entered into advanced due diligence on behalf of the Group in relation to four transactions which would add in excess of 450 beds.
The Investment Adviser has also entered into negotiations, which are currently at an earlier stage, on five further potential transactions, which would deliver over 1,500 additional beds to the Group.
These transactions, if completed, would add six new tenants further diversifying the Group’s rental income.
These acquisitions are subject to ongoing due diligence by the Investment Adviser and its professional advisers. The Company and its Investment Adviser will continue to exercise robust capital discipline to deliver value at the point of acquisition or investment.
This announcement contains inside information.
For further information please contact:
Impact Health Partners LLP via Newgate Communications
Winterﬂood Securities Limited
Tel: 020 3100 0000
Newgate Communications (PR Adviser)
Tel: 020 7680 6550
The Company’s LEI is 213800AX3FHPMJL4IJ53.
Further information on Impact Healthcare REIT is available at www.impactreit.uk
The Group is a real estate investment trust (“REIT”) which aims to provide shareholders with an attractive return, principally in the form of quarterly income distributions and with the potential for capital and income growth, through exposure to a diversified portfolio of healthcare real estate opportunities, in particular residential care homes. The Group’s investment policy is to acquire, renovate, extend and redevelop high quality healthcare real estate assets in the UK and lease those assets primarily to healthcare operators providing residential healthcare services under full repairing and insuring leases.
The Group has paid an aggregate dividend of 6.0 pence per share for the first 12 months from Admission, which equates to a yield of 6 per cent. per annum on the IPO Issue Price, payable in quarterly instalments.
The Group’s Ordinary Shares were admitted to trading on the main market of the London Stock Exchange, Specialist Fund Segment, on 7 March
This announcement which has been prepared by, and is the sole responsibility of, the Directors of the Company and has been approved for the purposes of section 21 of the Financial Services and Markets Act 2000 by Winterflood Securities Limited
(“Winterflood”), which is authorised and regulated by the Financial Conduct Authority.
This announcement is an advertisement and does not constitute a prospectus or a key information document (a “KID”) relating to the Company and does not constitute, or form part of, any offer or invitation to sell or issue, or any solicitation of any offer to subscribe for, any shares in Company in any jurisdiction nor shall it, or any part of it, or the fact of its distribution, form the basis of, or be relied on in connection with or act as any inducement to enter into, any contract therefor. Once published, copies of the prospectus will be available from www.impactreit.uk.
Recipients of this announcement who are considering acquiring ordinary shares following publication of the prospectus are reminded that any such acquisition must be made only on the basis of the information contained in the prospectus (which may be different from the information contained in this announcement) and following receipt of the KID, any subscription for ordinary shares will be subject to specific legal or regulatory restrictions in certain jurisdictions. Persons distributing this announcement must satisfy themselves that it is lawful to do so. The Company assumes no responsibility in the event that there is a violation by any person of such restrictions.
This document may not be published, distributed or transmitted by any means or media, directly or indirectly, in whole or in part, in or into the United States. This document does not constitute an offer to sell, or a solicitation of an offer to buy, securities in the United States. The securities mentioned herein have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the “US Securities Act”) or with any securities regulatory authority of any state or other jurisdiction of the United States and will not be offered, sold, exercised, resold, transferred or delivered, directly or indirectly, in or into the United States or to, or for the account
or benefit of, any US person (as defined under Regulation S under the US Securities Act). The Company has not been, and will not be, registered under the U.S. Investment Company Act of 1940, as amended.
Neither this announcement nor any copy of it may be: (i) taken or transmitted into or distributed in any member state of the European Economic Area (other than the United Kingdom and the Republic of Ireland), Canada, Australia, Japan or the Republic of South Africa or to any resident thereof, or (ii) taken or transmitted into or distributed in Japan or to any resident thereof. Any failure to comply with these restrictions may constitute a violation of the securities laws or the laws of any such jurisdiction. The distribution of this announcement in other jurisdictions may be restricted by law and the persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.
This announcement may include “forward-looking statements”. All statements other than statements of historical facts included in this announcement, including, without limitation, those regarding the Company’s financial position, business strategy, plans and objectives of management for future operations (including development plans and objectives relating to the Company’s products and services) are forward-looking statements. Forward-looking statements are subject to risks and uncertainties and accordingly the Company’s actual future financial results and operational performance may differ materially from the results and performance expressed in, or implied by, the statements. These factors include but are not limited to: changes in general market conditions, legislative or regulatory changes, changes in taxation regimes or development planning regimes, the Company’s ability to invest its cash and the proceeds of the Issue in suitable investments on a timely basis and the availability and cost of capital for future investments. These forward-looking statements speak only as at the date of this announcement. The Company expressly disclaims any obligation or undertaking to update or revise any forward-looking statements contained herein to reflect actual results or any change in the assumptions, conditions or circumstances on which any such statements are based unless required to do so by the Financial Services and Markets Act 2000, the Listing Rules
or Prospectus Rules of the Financial Conduct Authority or other applicable laws, regulations or rules.
Winterflood, which is authorised and regulated by the Financial Conduct Authority in the United Kingdon, and RBC Europe Limited (trading as RBC Capital Markets), which is authorised by the Prudential Regulatory Authority and regulated by the Financial Conduct Authority in the United Kingdom, are acting only for the Company in connection with the matters described in this announcement and neither Winterflood nor RBC Capital Markets are acting for or advising any other person, or treating any other person as its client, in relation thereto and will not be responsible for providing the regulatory protection afforded to clients of Winterflood nor RBC Capital Markets respectively or advice to any other person in relation to the matters contained herein. Neither RBC Capital Markets nor any of its directors, officers, employees, advisers or agents accepts any responsibility or liability whatsoever for this announcement, its contents or otherwise in connection with it or any other information relating to the Company, whether written, oral or in a visual or electronic format.